We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
24
Aug 2026
On the surface, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and limbic-predominant age-related TDP-43 encephalopathy (LATE) might seem like unrelated diseases.
24
Aug 2026
During typical aging and Alzheimer's disease progression, higher levels of a protein called tau are associated with more depressive symptoms.
24
Aug 2026
For people with blindness or who have low vision, moving around independently is a daily challenge. Harvard researchers have developed a new tool that could help such people navigate more quickly and safely, using nothing but a device they likely already have – a smartphone.
24
Aug 2026
People with a comprehensive understanding of palliative care are more likely to prefer end-of-life care at home or in a hospice. Among individuals with less understanding about palliative care, hospital care is preferred.